| Financial Year |
March 31 2023 |
| Monetary Funds |
15,189,255,163.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,697,946,498.55 |
| Accounts Receivable |
12,322,664,307.27 |
| Advances to Suppliers |
1,182,798,294.83 |
| Other Receivables |
166,463,713.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
27,588,448.62 |
| Inventories |
6,966,050,544.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,373,881,206.47 |
| Total Current Assets |
39,788,111,387.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,191,015,542.15 |
| Long-term Equity Investment |
32,136,082,216.35 |
| Investment Properties |
87,258,606.37 |
| Fixed Assetes |
43,852,944,955.50 |
| Under-construction Projects |
6,441,871,133.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,857,566,843.28 |
| R&D expenses |
90,351,220.68 |
| Goodwill |
1,385,109,978.68 |
| Long-Term Deferred and Prepaid Expenses |
617,126,679.47 |
| Deferred Income Tax Assets |
1,730,862,584.58 |
| Other Non-Current Assets |
1,161,410,831.59 |
| Sub-Total of Non-Current Assets |
101,192,649,205.44 |
| Total Assets |
140,980,760,593.39 |
| Short-Term Loans |
12,284,466,947.56 |
| Trading Financial liabilities |
29,232,357.98 |
| Notes Payable |
2,554,170,398.31 |
| Accounts Payable |
9,707,043,514.16 |
| Accounts Received In Advance |
40,065,399.01 |
| Employee Compensation Payable |
303,169,448.97 |
| Taxes Payable |
602,701,260.11 |
| Interest Payable |
-- |
| Dividend Payable |
370,386.27 |
| Other payables |
1,854,197,271.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,186,120,829.01 |
| Other Current Liabilities |
889,226,836.67 |
| Sub-Total of Current Liabilities |
31,709,147,814.73 |
| Long-term Loans |
31,917,655,988.82 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
664,976,251.66 |
| Special Payable |
-- |
| Estimatied Liabilities |
42,363,741.50 |
| Deferred Income Tax Liabilities |
1,626,937,512.87 |
| Other Non-Current Liabilities |
253,883,640.96 |
| Sub-Total of Non-Current Liabilities |
35,884,813,932.79 |
| Total Liabilities |
67,593,961,747.52 |
| Paid-In Capital(Or Share Stock) |
13,408,732,749.00 |
| Capital Surplus |
24,471,126,777.18 |
| Surplus Reserve |
5,224,008,035.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
17,157,860,654.80 |
| Minority Stockholder's Interest |
10,602,608,721.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
62,784,190,124.58 |
| Owner's Equity（Stockholder's Equity） |
73,386,798,845.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
140,980,760,593.39 |
